Stay updated on SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial

Sign up to get notified when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T11:57:02.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1 on the page.
    Difference
    0.1%
    Check dated 2026-02-06T09:14:29.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. The study content, eligibility criteria, and results remain unchanged.
    Difference
    0.1%
    Check dated 2026-01-15T10:30:42.000Z thumbnail image
  5. Check
    69 days ago
    Change Detected
    Summary
    The page now consolidates study locations under a single Locations section listing Florida, Illinois, Kentucky, and Virginia; separate location sections/pages for these states have been removed.
    Difference
    0.6%
    Check dated 2025-12-17T19:46:50.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 and removed Revision: v3.2.0 from the page.
    Difference
    0.1%
    Check dated 2025-11-26T08:24:20.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Deleted the site-wide notice about government funding and potential data currency. The study-specific information on the page remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-19T08:38:51.000Z thumbnail image

Stay in the know with updates to SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.